Loopbaan van Edward W. Bernton
Eerdere bekende functies van Edward W. Bernton
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
CytImmune Sciences, Inc.
 CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Hoofd Techniek/Wetenschap/O&O | - | - |
| PROTALEX, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
| Analytica Therapeutics, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Edward W. Bernton
| Georgetown University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Analytica Therapeutics, Inc. | |
CytImmune Sciences, Inc.
CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Health Technology |
Protalex, Inc.
 Protalex, Inc. Pharmaceuticals: MajorHealth Technology Protalex, Inc. engages in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and Immune Thrombocytopenia. Its lead product is PRTX-100 which is a bacterial protein known to modify aspects of the human immune system. The company was founded by John E. Doherty on September 17, 1999 and is headquartered in Florham Park, NJ. | Health Technology |
- Beurs
- Insiders
- Edward W. Bernton
- Ervaring
